Dirk Eggink

Background

About Dirk Eggink

Viruses and how to inhibit virus infections are subjects that always intrigued me. I did my PhD at the laboratory of Experimental Virology in the AMC Amsterdam and worked on the inhibition of HIV-1 entry by fusion inhibitors and escape mechanisms. In addition, I was involved in different projects focused on the immunogenicity and antigenicity of the HIV-1 envelope glycoprotein. After obtaining my PhD, I moved to New York to the lab of Peter Palese. I have been involved in a variety of projects, ranging from the development and characterization of broadly neutralizing antibodies using mouse hybridoma’s to the development of a universal influenza vaccine. To further pursue my work on the evolution and diversity of seasonal and zoonotic influenza viruses I joined the the Department of Medical Microbiology of the AMC Amsterdam in 2014 to address clinically and epidemiologically relevant questions pertaining to zoonotic influenza, in particular HPAI H5N1 viruses. I have establish sequencing and bioinformatic pipelines and a wide variety off molecular techniques to investigate genetic diversity and functional consequences of viral genes of interest.